{"product_id":"elv-pestel-analysis","title":"Elevance Health Inc. (ELV): PESTLE Analysis [June-2026 Updated]","description":"\u003cp\u003eDirect takeaway: This PESTLE analysis of Company Name frames macro forces-political, economic, social, technological, legal, and environmental-that affect a large health insurer managing regulatory scrutiny, subsidy shifts, and program-specific pressures. It condenses how those external factors influence growth, margins, cash flow, and risk exposure.\u003c\/p\u003e\n\u003cp\u003eThis ready-made PESTLE Analysis focuses on Company Name as a major health plan with \u003cstrong\u003e$197.6B\u003c\/strong\u003e operating revenue in 2025 and quarterly revenue of \u003cstrong\u003e$49.5B\u003c\/strong\u003e in Q1 2026, serving \u003cstrong\u003e45.4M\u003c\/strong\u003e medical members, including \u003cstrong\u003e1.9M\u003c\/strong\u003e Medicare Advantage and \u003cstrong\u003e8.5M\u003c\/strong\u003e Medicaid members. Political and legal factors cover CMS scrutiny, Medicaid funding pressures, ACA subsidy policy changes, and an ongoing \u003cstrong\u003e$935M\u003c\/strong\u003e accrual tied to Medicare Advantage data reporting. Economic factors consider premium trends and macro spending; social factors include demographics and member mix; technology covers IT investment and claims\/data systems; environmental factors assess operational resilience and sustainability. Use this for coursework, case studies, and policy-impacted business analysis. \u003c\/p\u003e\u003ch2\u003eElevance Health, Inc. - PESTLE Analysis: Political\u003c\/h2\u003e\n\n\u003cp\u003ePolitical risk matters directly to Elevance Health, Inc. because a large share of its business depends on public programs, state regulation, and federal rulemaking. Changes in Medicare Advantage, Medicaid, and Affordable Care Act policy can quickly change enrollment, reimbursement, margins, and administrative cost.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003ePolitical driver\u003c\/th\u003e\n\u003cth\u003eWhat changes\u003c\/th\u003e\n\u003cth\u003eBusiness impact for Elevance Health, Inc.\u003c\/th\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMS funding boost and MA sanctions risk\u003c\/td\u003e\n\u003ctd\u003eFederal payment updates, quality oversight, and enforcement actions\u003c\/td\u003e\n \u003ctd\u003eCan raise revenue, but poor compliance or quality scores can reduce bonus payments and increase penalties\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicaid redeterminations\u003c\/td\u003e\n\u003ctd\u003eStates recheck eligibility after federal continuous coverage rules ended\u003c\/td\u003e\n \u003ctd\u003eEnrollment can fall, state budgets tighten, and payment rates face pressure\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eACA subsidy policy\u003c\/td\u003e\n\u003ctd\u003eCongressional decisions on premium tax credit support\u003c\/td\u003e\n \u003ctd\u003eCoverage churn can rise, affecting exchange membership and administrative costs\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBlue Cross Blue Shield oversight\u003c\/td\u003e\n\u003ctd\u003eMulti-state licensing, conduct rules, and local market scrutiny\u003c\/td\u003e\n \u003ctd\u003eHigher compliance burden and slower strategic execution across states\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBudget cycles\u003c\/td\u003e\n\u003ctd\u003eFederal and state appropriations and rate-setting calendars\u003c\/td\u003e\n \u003ctd\u003eCreates timing risk for contract renewals, reimbursement, and planning\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eCMS funding boost and MA sanctions risk\u003c\/strong\u003e are two sides of the same political issue. Medicare Advantage, or MA, is a privately run Medicare option paid by the federal government. If CMS increases benchmark rates or improves quality-related payments, Elevance Health, Inc. can benefit through better top-line growth or margin support. But political and regulatory scrutiny is also intense. CMS can audit plans, cut Star Ratings-related bonus revenue, or impose sanctions for compliance failures, marketing violations, or claims issues. That matters because MA profitability depends on tight cost control, strong enrollment retention, and good quality scores. Even a small change in rating-driven payments can move earnings because Medicare businesses are built on large member volumes and thin operating margins.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMedicaid redeterminations driving state rate pressure\u003c\/strong\u003e is another direct political force. After the end of federal continuous Medicaid coverage protections, states restarted eligibility checks, which pushed millions of people off Medicaid nationwide. For a managed care company, that can reduce membership, change the risk mix, and force states to renegotiate payment rates. States often try to control spending when enrollment shifts, so rate updates may lag medical cost trends. That creates margin pressure if healthcare use stays high while state payments grow more slowly. It also raises administrative costs because eligibility changes, plan switching, and appeals increase paperwork and member service workloads.\u003c\/p\u003e\n\n\u003cp\u003eThe practical effect can be seen in the way state Medicaid budgets work. If enrollment falls after redeterminations, state officials may argue for lower capitation rates. If the remaining members are sicker, the opposite pressure can appear, but only after lengthy actuarial review. This makes Medicaid revenue politically sensitive and less predictable than commercial business.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eFewer eligible members can reduce premium revenue quickly.\u003c\/li\u003e\n \u003cli\u003eHigher churn raises call center, claims, and enrollment administration costs.\u003c\/li\u003e\n \u003cli\u003eState rate negotiations can lag actual medical inflation.\u003c\/li\u003e\n \u003cli\u003ePolicy changes can alter the mix between healthier and sicker members.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eExpiring ACA subsidies threatening coverage churn\u003c\/strong\u003e affects the individual exchange business. The enhanced premium tax credits expanded affordability for many ACA enrollees, and their expiration would likely make coverage less affordable for some households. That can lead to higher churn, meaning more people drop coverage, re-enroll later, or switch plans. For Elevance Health, Inc., churn matters because exchange members often buy and drop coverage based on monthly price sensitivity. More churn increases acquisition expense, weakens retention, and can disturb risk pool stability. If healthier members exit first, average claims cost can rise for the remaining pool, which hurts margins unless pricing is adjusted fast enough.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eMulti-state Blue Cross Blue Shield oversight burden\u003c\/strong\u003e adds a separate political layer. Operating through a Blue Cross Blue Shield brand structure across multiple states means the company faces overlapping state insurance departments, consumer protection rules, network adequacy standards, and local political pressure. Each state can have different filing requirements, rate review processes, and public policy priorities. That increases compliance staffing, slows product changes, and raises the risk of uneven state outcomes. It also limits how quickly the company can standardize operations across markets. For an academic analysis, this is important because the same national company still behaves like a collection of state-regulated businesses.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eOversight area\u003c\/th\u003e\n\u003cth\u003ePolitical source\u003c\/th\u003e\n\u003cth\u003eWhy it matters\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRate approvals\u003c\/td\u003e\n\u003ctd\u003eState insurance regulators\u003c\/td\u003e\n\u003ctd\u003eAffects pricing speed and margin protection\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMarket conduct exams\u003c\/td\u003e\n\u003ctd\u003eState attorneys general and insurance departments\u003c\/td\u003e\n \u003ctd\u003eRaises legal and administrative cost if practices are challenged\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNetwork adequacy\u003c\/td\u003e\n\u003ctd\u003eState and federal rules\u003c\/td\u003e\n\u003ctd\u003eCan force broader provider access and higher cost structures\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eConsumer complaints\u003c\/td\u003e\n\u003ctd\u003eState regulators and political offices\u003c\/td\u003e\n\u003ctd\u003eCan trigger investigations, reputational damage, and remediation cost\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eFederal and state budgeting cycles shaping government business\u003c\/strong\u003e affect contract timing and revenue visibility. Government healthcare business does not move on a normal commercial calendar. Federal Medicare rulemaking, state Medicaid budgets, and annual appropriations all shape when rates are set, how long contracts last, and how much uncertainty exists before each renewal. If state legislatures delay budgets, managed care contracts may be extended temporarily or priced conservatively. If federal budget negotiations create uncertainty, health plans may face delayed guidance on payment rules or benefit design. That can make earnings planning harder and can force the company to hold extra operational capacity before final rates are known.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eFederal rule changes can alter reimbursement with little warning.\u003c\/li\u003e\n \u003cli\u003eState budget stress can push down Medicaid rate growth.\u003c\/li\u003e\n \u003cli\u003eElection cycles can change priorities on coverage expansion, eligibility, and oversight.\u003c\/li\u003e\n \u003cli\u003eShort-term funding extensions can delay contract clarity and investment decisions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003ePolitical pressure also affects how public buyers think about healthcare inflation. When states face higher Medicaid spending or when Congress debates Medicare costs, managed care companies can become targets for stricter oversight, lower rate assumptions, or more aggressive reporting requirements. For Elevance Health, Inc., that means government business is not just about serving members; it is also about managing policy risk, legislative timing, and regulator expectations across many jurisdictions.\u003c\/p\u003e\u003ch2\u003eElevance Health, Inc. - PESTLE Analysis: Economic\u003c\/h2\u003e\n\n\u003cp\u003eElevance Health faces a cost environment where medical inflation can rise faster than premium pricing. That matters because the company earns profit when the premiums it collects exceed the medical claims it pays, so even a small spread between cost growth and pricing can squeeze margins quickly.\u003c\/p\u003e\n\n\u003cp\u003eThe most important economic pressure is medical cost inflation outpacing pricing. Hospital fees, physician reimbursements, pharmacy costs, and outpatient utilization can all move higher at the same time. If premium rate increases do not keep pace, Elevance Health has to absorb the gap through lower operating margin, tighter underwriting, or slower earnings growth. This is especially important in employer and government-sponsored plans, where pricing changes often lag actual claims trends.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eEconomic factor\u003c\/th\u003e\n\u003cth\u003eBusiness impact\u003c\/th\u003e\n\u003cth\u003eWhy it matters\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical cost inflation\u003c\/td\u003e\n\u003ctd\u003eRaises claims expense faster than premium revenue\u003c\/td\u003e\n \u003ctd\u003eCompresses underwriting margin and can weaken earnings\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBenefit expense ratio\u003c\/td\u003e\n\u003ctd\u003eMeasures how much premium is paid out in medical benefits\u003c\/td\u003e\n \u003ctd\u003eA higher ratio means less room for profit and admin costs\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInvestment income\u003c\/td\u003e\n\u003ctd\u003eAdds non-operating earnings from interest and investments\u003c\/td\u003e\n \u003ctd\u003eCan temporarily support earnings when core margins are under pressure\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCarelon expansion\u003c\/td\u003e\n\u003ctd\u003eProvides diversified earnings from health services and care solutions\u003c\/td\u003e\n \u003ctd\u003eCan offset slower growth in core health insurance operations\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMembership mix\u003c\/td\u003e\n\u003ctd\u003eChanges the share of commercial, Medicare, and Medicaid lives\u003c\/td\u003e\n \u003ctd\u003eAffects revenue visibility, cost volatility, and margin quality\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eThe elevated benefit expense ratio is another direct economic constraint. The benefit expense ratio shows how much of premium revenue is spent on medical claims and related benefits. When this ratio rises, it means a larger share of each premium dollar is going out to care instead of staying available for operating profit. For Elevance Health, a higher ratio often signals that pricing discipline is not fully keeping up with utilization trends, especially in high-need segments such as behavioral health, specialty drugs, and outpatient care.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eA higher benefit expense ratio reduces operating leverage.\u003c\/li\u003e\n \u003cli\u003eIt limits the company's ability to convert revenue growth into profit growth.\u003c\/li\u003e\n \u003cli\u003eIt can force stricter benefit design, tighter provider negotiations, or faster rate increases.\u003c\/li\u003e\n \u003cli\u003eIt makes earnings more sensitive to flu seasons, chronic disease trends, and pharmacy inflation.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eNon-recurring investment income can mask weakness in core operations. When interest rates are high, insurers can earn more from bond portfolios and cash balances, which may lift reported earnings even if underwriting performance softens. That is important for analysis because investment income is not the same as recurring premium and fee income. If earnings rely too much on portfolio returns, the underlying health of the insurance business may look stronger than it really is.\u003c\/p\u003e\n\n\u003cp\u003eCarelon growth helps offset slower expansion in Health Benefits. This matters economically because it diversifies revenue away from pure insurance margins. Carelon's services-oriented businesses can produce different margin characteristics, and that can reduce dependence on premium spread alone. If Health Benefits growth slows due to market competition, pricing pressure, or membership losses, stronger Carelon performance can stabilize total company revenue and support operating income.\u003c\/p\u003e\n\n\u003cp\u003eMembership mix is also changing the margin profile. A shift toward Medicare Advantage, Medicaid, employer, or exchange membership changes the economics of the business because each line carries different reimbursement rules, utilization patterns, and profitability levels. Commercial membership may price differently from government programs, while Medicaid can be more exposed to state rate updates and social need trends. This means mix shifts can either strengthen or weaken margins even when total membership stays stable.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eCommercial members usually give more pricing flexibility.\u003c\/li\u003e\n \u003cli\u003eMedicare and Medicaid members often create more regulation-linked cost pressure.\u003c\/li\u003e\n \u003cli\u003eExchange membership can be sensitive to subsidies, unemployment, and household income.\u003c\/li\u003e\n \u003cli\u003eA poorer mix can lower margin even if revenue rises.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe main economic test for Elevance Health is whether premium growth, service revenue growth, and investment income can keep ahead of claim inflation and utilization pressure. If not, the company must rely more on cost control, benefit design, and product mix changes to protect profitability.\u003c\/p\u003e\u003ch2\u003eElevance Health, Inc. - PESTLE Analysis: Social\u003c\/h2\u003e\n\u003cp\u003eElevance Health, Inc. is exposed to strong social forces because its core business depends on how people age, how they use health coverage, and how much they can afford to pay for care. The biggest social issues are older populations, uneven income growth, demand for simpler whole-health care, and rising distrust of opaque pricing and coverage decisions.\u003c\/p\u003e\n\n\u003cp\u003eThe aging population matters because older members use more care, especially primary care, chronic disease management, prescriptions, behavioral health, and post-acute services. In the US, the 65-and-older population is already more than \u003cstrong\u003e1 in 6\u003c\/strong\u003e people, and that share keeps rising. For Elevance Health, Inc., this creates higher demand for Medicare-related services, more complex utilization patterns, and greater need to coordinate care across doctors, hospitals, pharmacies, and home-based services. The opportunity is stable membership and higher care-management relevance. The risk is higher medical cost if care is not coordinated well.\u003c\/p\u003e\n\n\u003cp\u003ePublic-program churn is another social issue. Many members move in and out of Medicaid and subsidized exchange coverage as income, family status, or state eligibility rules change. This churn increases administrative complexity because members often change plans, lose continuity of care, and re-enter the system with untreated conditions. For Elevance Health, Inc., churn can raise costs tied to enrollment processing, care disruption, and member education. It also weakens long-term health outcomes, which matters because poor outcomes often lead to higher claims and lower satisfaction.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eSocial factor\u003c\/th\u003e\n\u003cth\u003eWhat is happening\u003c\/th\u003e\n\u003cth\u003eWhy it matters for Elevance Health, Inc.\u003c\/th\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAging population\u003c\/td\u003e\n\u003ctd\u003eMore people are moving into Medicare age and living longer with chronic conditions\u003c\/td\u003e\n \u003ctd\u003eHigher demand for care coordination, disease management, and Medicare-focused services\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic-program churn\u003c\/td\u003e\n\u003ctd\u003eMembers move between Medicaid, exchange plans, and employer coverage\u003c\/td\u003e\n \u003ctd\u003eMore enrollment disruption, higher admin work, and weaker continuity of care\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAffordability pressure\u003c\/td\u003e\n\u003ctd\u003eSubsidies and household budgets affect plan selection and retention\u003c\/td\u003e\n \u003ctd\u003eGreater sensitivity to premium pricing and product design\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOut-of-pocket costs\u003c\/td\u003e\n\u003ctd\u003eDeductibles, copays, and coinsurance affect whether people seek care\u003c\/td\u003e\n \u003ctd\u003eCan delay treatment, raise long-term claims, and affect member satisfaction\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrust and transparency\u003c\/td\u003e\n\u003ctd\u003eConsumers want clear prices, clear coverage rules, and fair treatment\u003c\/td\u003e\n \u003ctd\u003eStrong impact on reputation, retention, and regulator scrutiny\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eDemand for integrated whole-health services is rising. People no longer want care split into separate silos for physical health, behavioral health, pharmacy, and social needs. They want one system that can manage the full picture. This is important for Elevance Health, Inc. because integration can improve member experience, support better health outcomes, and reduce avoidable costs. If a member with diabetes also has depression and housing instability, treating only the diabetes often produces poor results. Whole-health coordination can improve adherence, reduce hospital use, and make the company's care model more valuable to employers, public programs, and individual members.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003ePhysical health and behavioral health are increasingly linked in member expectations.\u003c\/li\u003e\n \u003cli\u003eCare coordination is more valuable when members have multiple chronic conditions.\u003c\/li\u003e\n \u003cli\u003ePharmacy management matters because drug costs and adherence directly affect outcomes.\u003c\/li\u003e\n \u003cli\u003eSocial needs such as food access, transportation, and housing can influence medical claims.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eAffordability pressure is also tied to subsidy uncertainty. Many exchange members depend on premium subsidies to keep coverage within reach. When household budgets are tight or subsidy rules become less predictable, members become more price sensitive and may switch plans, delay coverage decisions, or drop insurance altogether. For Elevance Health, Inc., this can increase enrollment volatility in individual-market products. It also means product design has to balance richer benefits with premium discipline. If prices rise faster than wages, members often choose lower-cost plans even when those plans expose them to higher out-of-pocket spending later.\u003c\/p\u003e\n\n\u003cp\u003eRising sensitivity to out-of-pocket costs is one of the clearest social pressures in health insurance. Deductibles, copays, and coinsurance affect whether members actually use the benefits they buy. A plan may look affordable at the premium level but still feel expensive when a member faces a $500 deductible or a $40 specialist copay. That changes behavior. Members may skip preventive care, delay specialist visits, or avoid filling prescriptions. For Elevance Health, Inc., this can hurt both health outcomes and customer satisfaction. It also pushes the company to design benefits that improve perceived value without creating unsustainable claims exposure.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eAffordability pressure point\u003c\/th\u003e\n\u003cth\u003eMember behavior\u003c\/th\u003e\n\u003cth\u003eBusiness impact\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHigher premiums\u003c\/td\u003e\n\u003ctd\u003eMembers shop more aggressively and may downgrade plans\u003c\/td\u003e\n \u003ctd\u003ePressure on retention and pricing discipline\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHigh deductibles\u003c\/td\u003e\n\u003ctd\u003eMembers delay care or reduce service use\u003c\/td\u003e\n \u003ctd\u003eCan lower near-term claims but raise long-term medical risk\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialist copays\u003c\/td\u003e\n\u003ctd\u003eMembers may avoid follow-up visits\u003c\/td\u003e\n\u003ctd\u003eWeakens care adherence and may increase avoidable complications\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePrescription cost sharing\u003c\/td\u003e\n\u003ctd\u003eMembers may skip or split medications\u003c\/td\u003e\n\u003ctd\u003eRaises medical risk and can reduce pharmacy adherence metrics\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eTrust, equity, and transparency expectations are now central to how people judge health insurers. Members want clear explanations of coverage rules, prior authorization, claim denials, and network status. They also expect fair treatment across income groups, geographies, and racial or ethnic communities. This matters for Elevance Health, Inc. because distrust can increase complaint volume, reduce renewal rates, and attract scrutiny from regulators and employers. Equity expectations also push the company to show measurable progress in access, quality, and outcomes, not just broad public statements.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eClear coverage language reduces confusion and improves member confidence.\u003c\/li\u003e\n \u003cli\u003eTransparent pricing helps members compare plans and understand tradeoffs.\u003c\/li\u003e\n \u003cli\u003eEquity programs matter because uneven access can worsen outcomes and reputational risk.\u003c\/li\u003e\n \u003cli\u003eFaster claims and authorization decisions can improve trust and lower friction.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eFrom a strategic angle, these social trends favor health insurers that can combine scale with personalization. For Elevance Health, Inc., the best response is not just lower prices. It is simpler navigation, better care coordination, stronger behavioral health support, and clearer communication about costs and coverage. That mix helps the company compete in employer, Medicare, Medicaid, and individual markets where member experience now influences buying decisions as much as benefit design.\u003c\/p\u003e\n\u003ch2\u003eElevance Health, Inc. - PESTLE Analysis: Technological\u003c\/h2\u003e\n\u003cp\u003eTechnology is a core competitive driver for Elevance Health, Inc. because it shapes medical cost control, care access, member engagement, and administrative efficiency. The company's ability to use data, digital tools, and automation matters directly to margins, service quality, and regulatory compliance.\u003c\/p\u003e\n\n\u003cp\u003eLarge-scale AI investment across operations is important because health insurers work with very large claim, utilization, and care-management data sets. AI can speed up prior authorization review, detect fraud, identify high-risk members earlier, and improve customer service routing. For Elevance Health, Inc., the strategic value is not just lower operating cost; it is also better decision quality across medical management, pharmacy coordination, and case management. In a business with thin margins and heavy regulatory oversight, even small gains in processing speed or error reduction can matter.\u003c\/p\u003e\n\n\u003cp\u003eAnalytics-driven care across more than \u003cstrong\u003e90 million\u003c\/strong\u003e consumers gives Elevance Health, Inc. a scale advantage, but it also raises the bar for model governance. The larger the population, the more useful predictive analytics become for spotting patterns in chronic disease, care gaps, and avoidable emergency use. At the same time, large-scale analytics only work if the underlying data is clean, complete, and consistently linked across claims, pharmacy, provider, and care-management systems.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eTechnological area\u003c\/th\u003e\n\u003cth\u003eBusiness use\u003c\/th\u003e\n\u003cth\u003eWhy it matters for Elevance Health, Inc.\u003c\/th\u003e\n \u003cth\u003eRisk if weak\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAI in operations\u003c\/td\u003e\n\u003ctd\u003eClaims review, automation, member support, fraud detection\u003c\/td\u003e\n \u003ctd\u003eLowers administrative burden and speeds decisions\u003c\/td\u003e\n \u003ctd\u003eHigher cost, slower service, more errors\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAnalytics at scale\u003c\/td\u003e\n\u003ctd\u003eRisk scoring, care gap detection, population health management\u003c\/td\u003e\n \u003ctd\u003eImproves care targeting across more than \u003cstrong\u003e90 million\u003c\/strong\u003e consumers\u003c\/td\u003e\n \u003ctd\u003eMissed interventions and weaker medical cost control\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital coordination\u003c\/td\u003e\n\u003ctd\u003eMember apps, provider communication, care navigation\u003c\/td\u003e\n \u003ctd\u003eIncreases engagement and reduces friction in care delivery\u003c\/td\u003e\n \u003ctd\u003eLower adoption and weaker retention\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eData controls\u003c\/td\u003e\n\u003ctd\u003eValidation, access control, audit trails, data lineage\u003c\/td\u003e\n \u003ctd\u003eProtects accuracy, privacy, and compliance\u003c\/td\u003e\n \u003ctd\u003eModel errors, security incidents, and regulatory penalties\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eDigital care coordination through Sydney Health is strategically important because health insurance is increasingly judged by ease of use, not just coverage design. A member app can connect benefits, claims, provider search, prescription information, reminders, and care guidance in one place. That reduces friction for users and also lowers call-center demand when the app answers common questions faster than a live representative can. For academic analysis, this is a clear example of technology changing both the customer experience and the cost base.\u003c\/p\u003e\n\n\u003cp\u003eHome-health and clinical orchestration through CareBridge strengthens Elevance Health, Inc. in a segment where care often shifts outside traditional hospitals. Orchestration technology helps coordinate services, scheduling, documentation, and communication among caregivers, clinicians, and family members. That matters because home-based care can be less expensive than facility-based care when it is managed well. It also fits the broader industry move toward care delivered in lower-cost settings, especially for members with complex needs.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eAI can reduce manual work in claims and care management.\u003c\/li\u003e\n \u003cli\u003eAnalytics can improve early intervention for high-risk members.\u003c\/li\u003e\n \u003cli\u003eMobile tools can increase member engagement and self-service use.\u003c\/li\u003e\n \u003cli\u003eHome-care coordination can support lower-cost care settings.\u003c\/li\u003e\n \u003cli\u003eData controls can reduce compliance and model-risk exposure.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eData integrity controls are becoming mission-critical because technology only creates value when the data is trustworthy. In health insurance, bad data can cause wrong risk scores, incorrect care recommendations, payment errors, and weak reporting to regulators and partners. Elevance Health, Inc. needs strong controls over data quality, identity matching, access permissions, audit trails, and vendor integration. This is especially important when AI systems are used, because AI can amplify errors if the input data is incomplete or biased.\u003c\/p\u003e\n\n\u003cp\u003eFrom a strategic perspective, the main technological pressure is balancing automation with oversight. The company can use technology to scale services across a very large membership base, but it must still prove that decisions are accurate, explainable, and compliant. That makes technology not just an efficiency tool, but a core part of risk management and competitive positioning.\u003c\/p\u003e\u003ch2\u003eElevance Health, Inc. - PESTLE Analysis: Legal\u003c\/h2\u003e\n\u003cp\u003eLegal risk is one of the most important external pressures on Elevance Health, Inc. because its revenue depends on compliance-heavy public programs, state insurance rules, and federal disclosure standards. The company's legal exposure is not limited to fines; it can also mean payment recoupments, restricted product changes, slower plan approvals, and higher administrative cost.\u003c\/p\u003e\n\n\u003cp\u003eThe biggest legal issue is that Elevance Health, Inc. operates in a setting where regulators can review both the accuracy of reported data and the way the company designs, markets, and administers benefits. That matters because small compliance failures can affect large membership bases and trigger financial penalties or contract actions.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eLegal area\u003c\/td\u003e\n\u003ctd\u003eMain requirement\u003c\/td\u003e\n\u003ctd\u003eBusiness impact\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare Advantage data reporting\u003c\/td\u003e\n\u003ctd\u003eAccurate enrollment, encounter, risk, and quality data submission\u003c\/td\u003e\n \u003ctd\u003eAudit risk, payment adjustments, and corrective action costs\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicaid compliance\u003c\/td\u003e\n\u003ctd\u003eState-specific eligibility, claims, appeals, and service rules\u003c\/td\u003e\n \u003ctd\u003eHigher operating cost and risk of contract penalties\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDisclosure and governance\u003c\/td\u003e\n\u003ctd\u003eClear reporting to shareholders on risk, reserves, and controls\u003c\/td\u003e\n \u003ctd\u003eGreater scrutiny from investors and proxy advisers\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInsurance licensing\u003c\/td\u003e\n\u003ctd\u003eState-by-state filings, approvals, and rate reviews\u003c\/td\u003e\n \u003ctd\u003eSlower rollout of products and benefit changes\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBenefit redesign\u003c\/td\u003e\n\u003ctd\u003eRules on notice, formularies, cost sharing, and member protections\u003c\/td\u003e\n \u003ctd\u003eLimits on speed and flexibility of plan changes\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eCMS enforcement risk over Medicare Advantage data reporting\u003c\/strong\u003e is a major legal pressure point. CMS uses reported data to validate enrollment, payments, quality performance, and clinical encounter information. If Elevance Health, Inc. submits data that CMS views as incomplete, late, or inaccurate, the company can face audits, refunds, penalties, and reputational damage. This is especially sensitive in Medicare Advantage because payment and oversight are tied closely to reported member characteristics and service activity. The legal risk is not just the error itself; it is also the cost of internal remediation, outside review, and staff time spent responding to regulators.\u003c\/p\u003e\n\n\u003cp\u003eThis risk matters strategically because it can affect earnings quality. If reported data is challenged, the company may need to reserve for repayment exposure or tighten compliance controls, which raises overhead. For an academic analysis, this shows how legal compliance can directly shape margins, not just administrative processes.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eData validation failures can trigger post-payment review.\u003c\/li\u003e\n \u003cli\u003eAudit findings can force corrective action plans.\u003c\/li\u003e\n \u003cli\u003eRepeated issues can increase regulator attention across multiple product lines.\u003c\/li\u003e\n \u003cli\u003eCompliance weakness can raise the cost of growth in Medicare Advantage.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eMedicare and Medicaid compliance burden\u003c\/strong\u003e is structurally high because the rules differ by program and often by state. Medicare has federal standards for benefits, appeals, marketing, network adequacy, and member protections. Medicaid adds a second layer of state-level contract terms, reporting formats, and service obligations. Elevance Health, Inc. has to maintain separate operational controls for claims, prior authorization, utilization management, grievances, and provider payment rules. That means compliance is not a single function; it is embedded in product design, member service, provider relations, and finance.\u003c\/p\u003e\n\n\u003cp\u003eThe business impact is clear: more compliance layers mean more cost and slower execution. A new plan rule or state directive can require system changes, staff training, revised member notices, and new reporting cycles. That reduces flexibility and can delay product fixes or benefit updates. In financial terms, this often shows up as higher operating expense and more conservative reserve management. If a compliance issue affects claims processing or enrollment, it can also distort short-term revenue recognition and cash flow timing.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eProgram\u003c\/td\u003e\n\u003ctd\u003ePrimary legal focus\u003c\/td\u003e\n\u003ctd\u003eOperational burden\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare Advantage\u003c\/td\u003e\n\u003ctd\u003eFederal reporting, marketing, access, and quality rules\u003c\/td\u003e\n \u003ctd\u003eHigh documentation and audit burden\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicaid managed care\u003c\/td\u003e\n\u003ctd\u003eState contract terms, service levels, and appeals\u003c\/td\u003e\n \u003ctd\u003eHigh variation across states\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCommercial insurance\u003c\/td\u003e\n\u003ctd\u003eRate filing, disclosures, network rules, and consumer protections\u003c\/td\u003e\n \u003ctd\u003eFrequent state approvals and filings\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eGovernance and disclosure scrutiny from shareholders\u003c\/strong\u003e is another legal pressure. Investors expect clear disclosure on medical cost trends, regulatory investigations, reserve adequacy, and compliance controls. If shareholders believe the company is not transparent enough about legal exposure, they may push for board changes, stricter oversight, or more detailed risk reporting. This matters because health insurance is a trust-based business: investors want to know that earnings are not being supported by weak controls or aggressive assumptions.\u003c\/p\u003e\n\n\u003cp\u003eFor Elevance Health, Inc., governance scrutiny can affect capital allocation and management accountability. Strong disclosure can reduce uncertainty in valuation because investors can better judge the durability of earnings and the risk of future charges. Weak disclosure can do the opposite by increasing the discount applied to the company's earnings. In academic work, this is a useful example of how legal and governance risks influence market confidence even when operating performance looks stable.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003eShareholders may demand more detail on litigation and regulatory exposure.\u003c\/li\u003e\n \u003cli\u003eProxy pressure can increase if board oversight looks weak.\u003c\/li\u003e\n \u003cli\u003eDisclosure quality affects investor trust and valuation multiples.\u003c\/li\u003e\n \u003cli\u003eInadequate controls can lead to restatements or remediation costs.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eMulti-state insurance licensing and filing complexity\u003c\/strong\u003e creates a legal barrier to speed. Elevance Health, Inc. operates in a regulated industry where insurance products usually require state-by-state licensing, form approvals, rate filings, and ongoing compliance with local insurance departments. Even when the underlying product is similar, filing rules can differ across states. That means the company cannot roll out a change once and apply it everywhere. It must often tailor language, benefits, pricing, and notices to each jurisdiction.\u003c\/p\u003e\n\n\u003cp\u003eThis legal structure affects expansion strategy. Faster product growth requires more legal and regulatory staffing, stronger state-level government relations, and tighter coordination between actuarial, legal, and operations teams. It also means that a delay in one state can disrupt a broader product launch. For a student paper, this is a clear example of how regulation shapes market entry barriers and slows standardization across a national platform.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eRegulatory rules shaping benefit redesign speed\u003c\/strong\u003e can limit how quickly Elevance Health, Inc. adjusts coverage, cost sharing, and supplemental benefits. In public programs and regulated commercial lines, the company often needs to submit notices, obtain approvals, and meet consumer protection standards before making changes. That slows the pace at which management can respond to higher medical costs, new utilization patterns, or competitive pressure. Legal rules therefore affect not only compliance but also product agility.\u003c\/p\u003e\n\n\u003cp\u003eThis matters because benefit design is a major competitive tool. If the company cannot redesign benefits quickly, it may have less room to protect margins or match competitors. On the other hand, strict legal review can also reduce the risk of consumer complaints and regulatory disputes. The trade-off is simple: more legal control usually means less speed, but it can also mean more durable operating discipline.\u003c\/p\u003e\n\n\u003cul\u003e\n\u003cli\u003ePrior approval can delay benefit changes by state.\u003c\/li\u003e\n \u003cli\u003eMember notice rules reduce how fast pricing and coverage can shift.\u003c\/li\u003e\n \u003cli\u003eFederal and state consumer protections limit abrupt plan redesign.\u003c\/li\u003e\n \u003cli\u003eSlower redesign can protect compliance but reduce competitive agility.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003eLegal constraint\u003c\/td\u003e\n\u003ctd\u003eWhy it matters\u003c\/td\u003e\n\u003ctd\u003eLikely company response\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCMS data audits\u003c\/td\u003e\n\u003ctd\u003eCan affect payment integrity\u003c\/td\u003e\n\u003ctd\u003eStronger internal controls and validation\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedicare and Medicaid rules\u003c\/td\u003e\n\u003ctd\u003eIncrease operating complexity\u003c\/td\u003e\n\u003ctd\u003eMore compliance staff and process automation\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eShareholder disclosure pressure\u003c\/td\u003e\n\u003ctd\u003eCan affect investor confidence\u003c\/td\u003e\n\u003ctd\u003eMore detailed risk reporting and governance oversight\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eState licensing and filings\u003c\/td\u003e\n\u003ctd\u003eSlows product rollout\u003c\/td\u003e\n\u003ctd\u003eMore legal coordination by state\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBenefit redesign restrictions\u003c\/td\u003e\n\u003ctd\u003eLimits pricing and product flexibility\u003c\/td\u003e\n\u003ctd\u003eEarlier planning and more conservative design changes\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\u003ch2\u003eElevance Health, Inc. - PESTLE Analysis: Environmental\u003c\/h2\u003e\n\n\u003cp\u003eEnvironmental factors matter to Elevance Health, Inc. because weather shocks, public health events, and sustainability pressure can change demand, raise operating costs, and disrupt service delivery. For a health benefits and care services company, environmental risk is not limited to facilities; it also affects member access, claims volume, provider capacity, and continuity of care.\u003c\/p\u003e\n\n\u003cp\u003eClimate-related disruptions can increase health demand in several ways. Heat waves, wildfires, floods, and hurricanes can worsen respiratory illness, trigger injury claims, interrupt medication access, and increase mental health needs. When extreme weather hits, members often need faster triage, telehealth access, prescription refill flexibility, and care coordination. This can lift short-term utilization, especially in emergency rooms, urgent care, and behavioral health. It can also increase administrative work for eligibility changes, out-of-network exceptions, and disaster-related claims handling.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003ctr\u003e\n\u003cth\u003eEnvironmental factor\u003c\/th\u003e\n\u003cth\u003eBusiness impact on Elevance Health, Inc.\u003c\/th\u003e\n \u003cth\u003eWhy it matters strategically\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClimate-related disruptions\u003c\/td\u003e\n\u003ctd\u003eHigher claims activity, care access problems, and temporary service interruptions\u003c\/td\u003e\n \u003ctd\u003eAffects medical cost trends and member satisfaction\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSustainability scrutiny\u003c\/td\u003e\n\u003ctd\u003eGreater pressure to disclose emissions, governance, and supplier practices\u003c\/td\u003e\n \u003ctd\u003eInfluences investor confidence and reputation\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHome-based care\u003c\/td\u003e\n\u003ctd\u003eMore flexible care delivery during disasters and regional disruptions\u003c\/td\u003e\n \u003ctd\u003eImproves continuity of care and reduces dependence on physical sites\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eLarge operational footprint\u003c\/td\u003e\n\u003ctd\u003eHigher energy, water, and waste management needs across offices and service facilities\u003c\/td\u003e\n \u003ctd\u003eRaises cost and compliance exposure\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEnvironmental continuity risk\u003c\/td\u003e\n\u003ctd\u003eNetwork disruption, data center risk, and staffing shortages during events\u003c\/td\u003e\n \u003ctd\u003eThreatens claims processing and service reliability\u003c\/td\u003e\n \u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cp\u003eSustainability indices and ESG screening can raise scrutiny on Elevance Health, Inc. even though it is not a heavy industrial company. Large institutional investors often assess climate disclosure, board oversight, workforce resilience, and supplier standards. ESG means environmental, social, and governance factors. In practical terms, that means investors may look at how the company manages energy use, business continuity, data-center resilience, procurement risk, and climate-related stress on members and employees. Poor disclosure or weak targets can affect valuation multiples, especially when investors compare the company with peers that publish clearer sustainability metrics.\u003c\/p\u003e\n\n\u003cp\u003eHome-based care supports disaster resilience because it reduces dependence on physical facilities. If a storm, flood, or wildfire disrupts local hospitals or clinics, telehealth, nurse visits, medication delivery, and care management can keep many services running. For Elevance Health, Inc., that matters because it can protect continuity in care coordination and reduce avoidable emergency utilization. Home-based care also fits member preferences and can lower the need for travel during local disruptions. That said, it depends on reliable broadband, stable supply chains, and safe local conditions for visiting staff.\u003c\/p\u003e\n\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e\n\u003cstrong\u003eClimate shocks\u003c\/strong\u003e can increase short-term medical claims and behavioral health demand.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eTelehealth and home-based care\u003c\/strong\u003e improve resilience when clinics or hospitals are disrupted.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eESG scrutiny\u003c\/strong\u003e can affect investor perception, disclosure quality, and cost of capital.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003ePhysical operations\u003c\/strong\u003e create energy, waste, and continuity management pressure.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eNetwork resilience\u003c\/strong\u003e is critical because service interruptions can damage trust quickly.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eElevance Health, Inc. also faces resource pressure from its large operational footprint. Even without manufacturing plants, the company still runs offices, service centers, data systems, and vendor networks across many states. That creates indirect environmental exposure through electricity use, heating and cooling demand, paper consumption, business travel, and waste management. The broader the footprint, the more important it becomes to control resource use while keeping service levels high. Energy efficiency and digital workflows matter because they can reduce operating costs and support ESG goals at the same time.\u003c\/p\u003e\n\n\u003cp\u003eEnvironmental risk is tied directly to enterprise continuity. A major weather event can affect employees, members, providers, pharmacies, and third-party administrators at the same time. If call centers, claims systems, or cloud providers are interrupted, the company may face delayed authorizations, slower claims payment, and member complaints. That makes disaster recovery planning, backup communications, flexible staffing, and vendor diversification important operational safeguards. For academic work, the key point is that environmental risk is not just a reputational issue; it can affect claims severity, service delivery, and the stability of the whole health benefits model.\u003c\/p\u003e\n\n\u003cp\u003eThe main strategic challenge is balancing resilience and efficiency. Elevance Health, Inc. needs enough redundancy to keep services running during environmental shocks, but not so much duplication that costs rise unnecessarily. The companies that handle this well usually combine digital claims systems, remote care options, supplier oversight, and crisis-response protocols. That reduces exposure to local disruptions and helps protect member experience when external environmental pressure increases.\u003c\/p\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":44602930823317,"sku":"elv-pestel-analysis","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/elv-pestel-analysis.png?v=1740169452","url":"https:\/\/dcf-analysis.com\/products\/elv-pestel-analysis","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}